Lexeo Therapeutics Inc

Insider sales at Lexeo Therapeutics show tax‑driven moves amid volatile biotech, but COO’s February purchase hints at long‑term optimism—watch for clinical milestones.

Executive equity purchases at Lexeo Therapeutics signal leadership confidence amid market swings—watch key clinical milestones to gauge future upside.